Haematological and biochemical reference intervals for infants and children in Gabon

Alexander Humberg1, Judith Kammer, Benjamin Mordmüller

  • 1Medical Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon.

Insights

This study established crucial hematological and biochemical reference intervals for Gabonese infants and children. These findings highlight population-specific variations in blood parameters, essential for accurate clinical diagnosis.

Area of Science:

  • Clinical Biochemistry
  • Hematology
  • Pediatric Health

Background:

  • Establishing population-specific reference intervals is vital for accurate medical diagnosis.
  • Previous studies have shown variations in hematological parameters across different ethnic groups.

Purpose of the Study:

  • To determine reference intervals for key hematological and biochemical markers in Gabonese infants and children.
  • To provide a benchmark for clinical laboratory testing in Central Africa.

Main Methods:

  • Analyzed blood samples from 226 healthy infants (4-9 weeks) and 185 healthy children (18-60 months).
  • Measured red blood cell parameters, white blood cell counts, glutamate-pyruvic transaminase, creatinine, and total bilirubin.
  • Utilized nonparametric methods to establish 95% reference limits according to Clinical and Laboratory Standards Institute guidelines.

Main Results:

  • Gabonese children exhibited lower hemoglobin, hematocrit, red blood cell count, and mean corpuscular volume compared to European populations.
  • Higher platelet counts were observed in the Gabonese cohort.
  • Elevated eosinophil counts in older children suggest a potential link to intestinal helminth infections.

Conclusions:

  • The study underscores the necessity of local reference ranges for pediatric populations.
  • These established reference intervals serve as a valuable benchmark for similar Central African populations.
  • Understanding regional variations in hematological and biochemical parameters improves diagnostic accuracy.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...